AIMZ Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$823K Buy
686
+75
+12% +$76.6K 0.23% 84
2026
Q1
$562K Buy
611
+27
+5% +$27.4K 0.17% 89
2025
Q4
$628K Hold
584
0.18% 87
2025
Q3
$446K Hold
584
0.14% 94
2025
Q2
$455K Hold
584
0.15% 93
2025
Q1
$483K Buy
584
+81
+16% +$67.4K 0.17% 90
2024
Q4
$388K Hold
503
0.13% 97
2024
Q3
$446K Hold
503
0.15% 90
2024
Q2
$455K Hold
503
0.16% 87
2024
Q1
$391K Hold
503
0.15% 92
2023
Q4
$293K Hold
503
0.12% 96
2023
Q3
$270K Hold
503
0.12% 97
2023
Q2
$236K Buy
+503
New +$211K 0.1% 106

Other funds holding LLY

AIMZ Investment Advisors's LLY Position: Q2 2026 in Review

AIMZ Investment Advisors increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $76.6K and bringing the position to 686 shares worth $823K. The position accounts for 0.23% of the portfolio, ranked #84.

AIMZ Investment Advisors first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • AIMZ Investment Advisors held 686 shares of Eli Lilly worth $823K as of Q2 2026.
  • AIMZ Investment Advisors bought 75 Eli Lilly shares in Q2 2026, an estimated $76.6K.
  • Eli Lilly made up 0.23% of AIMZ Investment Advisors's portfolio in Q2 2026, its #84 holding.
  • AIMZ Investment Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on AIMZ Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.